1. Introduction {#sec1}
===============

*Acanthopanax sessiliflorus*, of the family *Araliaceae*, is abundant in Korea, China, Russia, and Japan. More than 30 *Acanthopanax* species grow in East Asia; more than 18 are known in Korea \[[@B1]\]. *Acanthopanax* species have been used in traditional medicine to make tonics, sedatives, and antispasmodics and to treat rheumatoid arthritis, diabetes, bacterial infections, cancer, and hypertension \[[@B2]--[@B4]\]. Various phytochemicals, such as lignans, steroids, and triterpenoidal saponins, have been identified in *Acanthopanax* species \[[@B5]--[@B8]\]. The major active component in these plants is lignan, and it has been determined that lignan plays a key role in the therapeutic effects \[[@B9], [@B10]\].

Various molecules are involved in the induction and maintenance of inflammatory responses. In addition to major cytokines, such as interleukin- (IL-) 1, IL-6, and tumor necrosis factor- (TNF-) *α*, prostaglandin and nitric oxide (NO), which is synthesized by inducible NO synthase (iNOS), are important chemical mediators of inflammation \[[@B11]\]. Prostaglandin is synthesized by two cyclooxygenase (COX) isoforms, COX-1 and inducible COX-2. Therefore, the inhibition and/or downregulation of these proinflammatory molecules may exert anti-inflammatory effects in arthritis \[[@B12]\].

Recent studies have been conducted to enhance the physiological activity of materials by fermentation using microorganisms such as fungi, yeast, lactic acid bacteria, and mushrooms. The benefits include nonsecondary pollution, a mild reaction, and the low cost of biotransformation. Microorganisms have many bioconversion elements. As a part of our previous related work \[[@B13]\], inhibitory activities of nitric oxide (NO) production, iNOS and COX-2, proinflammatory cytokines (IL-6 and tumor necrosis factor-*α*), and collagenase in lipopolysaccharide- (LPS-) treated RAW 264.7 macrophage cells were evaluated on the biotransformation product of *A*. *sessiliflorus*.

2. Materials and Methods {#sec2}
========================

2.1. Plant Material {#sec2.1}
-------------------

In April 2018, the bark of *A. sessiliflorus* was collected from Pyeongtaek, Republic of Korea, and certified by Dr. Kim (National Arboretum, Pocheon). In addition, a voucher specimen (201804-AS) was deposited at the herbarium of the College of Pharmacy, Chung-Ang University.

2.2. Fermentation {#sec2.2}
-----------------

*Lactobacillus plantarum* subsp. *argentoratensis* was selected for this study, on the basis of a previous study \[[@B14]\]. *L. plantarum* subsp. *argentoratensis* was purchased from the Korean Agricultural Culture Collection (Seoul, Korea), inoculated into MRS broth, and grown at 37°C and 200 rpm for 48 h. Then, 1% (v/v) *L. plantarum* subsp. *argentoratensis* was inoculated into MRS medium with 1% (w/v) *A. sessiliflorus* extract, and fermentation was performed at 37°C and 200 rpm for 5 days. After fermentation, centrifugation was performed for 20 min at 3000 rpm, and the supernatant was evaporated to obtain the fermented *A. sessiliflorus* (FAS) extract.

2.3. General Experimental Procedure {#sec2.3}
-----------------------------------

Chromatography was performed using the Sephadex LH-20 column (10--24 *μ*m; GE Healthcare Bio-Science AB, Uppsala, Sweden), MCI-gel CHP 20P (75--150 *μ*m; Mitsubishi Chemical, Tokyo, Japan), and ODS-B gel (40--60 *μ*m; Daiso, Osaka, Japan). Thin-layer chromatography (TLC) was performed using a precoated silica gel 60 F~254~ plate (Merck, Darmstadt, Germany) and chloroform : methanol (15 : 1, volume ratio) and chloroform : methanol : water (80 : 20 : 2 or 6 : 4:1). The spots were detected by application of a FeCl~3~ spray and 10% H~2~SO~4~ or anisaldehyde-H~2~SO~4~, followed by heat and UV irradiation (254 nm). The chemical structures were elucidated by using several types of instrumental analysis. 1D-nuclear magnetic resonance (NMR) experiments, such as ^1^H-(600 MHz) and ^13^C-(150 MHz) NMR, were performed using an JNM-ECZ600R (JEOL, Massachusetts, USA) at the Center for Research facilities at Chung-Ang University.

2.4. Extraction and Isolation {#sec2.4}
-----------------------------

The barks of *A. sessiliflorus* (3.2 kg) were extracted four times with 70% ethanol at room temperature for 3 days. The ethanol was removed under vacuum, and 143.03 g of the extract (AS) was obtained. Sixty grams of the extract was fermented by using *L. plantarum* subsp. *Argentoratensis*; the rest was stored at −20°C. The FAS extract was subjected to Sephadex LH-20 column chromatography and eluted with MeOH : H~2~O gradient (from 0 : 10 to 10 : 0); six subfractions (fr-1 to 6) were obtained. Repeated column chromatography of fr-2 using an MCI gel column with a gradient solvent system of MeOH : H~2~O (from 0 : 10 to 10 : 0) yielded **1** (acanthoside D, 119.5 mg), **2** (acanthoside B, 1.78 g), and **3** (daucosterol, 13 mg). fr-3 yielded **4** (protocatechuic acid, 693.5 mg), **5** (chlorogenic acid methyl ester, 476.6 mg), **6** (ciwujiatone, 9 mg), **7** (syringaresinol, 890.5 mg), and **8** (farnesol, 1.43 g). fr-4 yielded **9** (3,4-dicaffeoylquinic acid, 73 mg) and **10** (falcarindiol, 60.2 mg).

2.5. HPLC Analysis {#sec2.5}
------------------

The compounds in the FAS extract were compared with those in the AS extract by using high-pressure liquid chromatography (HPLC). The mobile phase consisted of solvent A (0.2% acetic acid in H~2~O) and B (acetonitrile (ACN); [Table 1](#tab1){ref-type="table"}). The extracts were dissolved in 50% MeOH.

2.6. RAW 264.7 Cell Culture {#sec2.6}
---------------------------

Murine macrophage RAW 264.7 cells were purchased from the Korean Cell Line Bank (Seoul, Korea). The cells were grown in Dulbecco\'s modified Eagle\'s medium (DMEM; Welgene, Gyeongbuk, Korea) supplemented with 10% fetal bovine serum (Welgene), 100 IU/mL penicillin G, and 100 mg/mL streptomycin (Gibco BRL, Grand Island, NY, USA) at 37°C in a humidified atmosphere (approximately 5% CO~2~), and the cells were counted by using a hemocytometer.

2.7. Measurement of Cell Viability {#sec2.7}
----------------------------------

The cytotoxicity was measured by the mitochondrial-dependent reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-bromide (MTT; Sigma, St. Louis, MO, USA) to formazan. RAW 264.7 cells were seeded in 96-well plates at a density of 1 × 10^5^ cells/mL. After incubation for 16 h at 37°C, the cells were treated with 20 *μ*L of each sample in serum-free DMEM and incubated at 37°C in a humidified atmosphere for 24 h. The medium was then removed, and MTT solution (100 *μ*L; 0.5 mg/mL) was added to each well. After incubation for 4 h, the supernatant was aspirated. The formazan crystals in each well were dissolved in 100 *μ*L dimethyl sulfoxide, and the absorbance at 540 nm was measured by using an enzyme-linked immunosorbent assay (ELISA) plate reader (Tecan Co. Ltd., Salzburg, Australia). Relative cell viability was evaluated from the quantity of MTT converted to the insoluble formazan salt compared with distilled water as the control. The cell viability was calculated as given in the following:$$\begin{matrix}
{\text{cell viability} = \frac{\text{sample OD}}{\text{control OD}}\, \times 100.} \\
\end{matrix}$$

2.8. Analysis of Inhibition of NO Production {#sec2.8}
--------------------------------------------

RAW 264.7 cells (2 × 10^5^ cells/well) were seeded in 96-well plates and incubated for 16 h at 37°C in a humidified atmosphere (approximately 5% CO~2~). The cells were incubated in a serum-free medium containing the sample and 1 *μ*g/mL LPS (Sigma, St. Louis, MO, USA). After incubation for an additional 20 h, the NO content was evaluated by using the Griess assay. The supernatant was obtained, Griess reagent (0.1% naphthylethylenediamine and 1% sulphanilamide in 5% H~3~PO~4~ solution; Sigma, St. Louis, MO, USA) was added, and the absorbance at 540 nm was recorded. N^G^-monomethyl-L-arginine monoacetate salt (L-NMMA) was used as the positive control. The inhibition of NO production was calculated from equation ([2](#EEq2){ref-type="disp-formula"}). The IC~50~ value was defined as the concentration that inhibited 50% of NO production:$$\begin{matrix}
{\text{inhibition rate }\left( \text{\%} \right) = 100 - \frac{\left( {\text{sample OD} - \text{blank OD}} \right)}{\left( {\text{control OD} - \text{blank OD}} \right)}\, \times 100.} \\
\end{matrix}$$

2.9. Determination of Proinflammatory Cytokine Levels {#sec2.9}
-----------------------------------------------------

The concentrations of IL-6 and TNF-*α* were determined by using ELISA. RAW 264.7 cells (1 × 10^6^ cells/well) were seeded in 6-well plates and preincubated for 16 h; subsequently, the samples were treated with LPS (1 *μ*g/mL) for 24 h to induce the production of cytokines. The supernatant was evaluated using an ELISA kit (Youngin Frontier, Seoul, Korea) in accordance with the manufacturer\'s instructions. The cytokine concentrations were quantified by measuring the absorbance at 450 nm.

2.10. Western Blotting Analysis {#sec2.10}
-------------------------------

RAW 264.7 cells (1 × 10^6^ cells/mL) were preincubated for 16 h and then treated with LPS (1 *μ*g/mL). After incubation for 24 h, the cells were harvested and washed twice with phosphate-buffered saline. The cell lysates were prepared in RIPA buffer (50 mM/L Tris--HCl \[pH 7.4\], 150 mM/L NaCl, 1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS), and 1 mM/L EDTA; Thermo Fisher Scientific, MA, USA) for 30 min on ice. The cell lysates were centrifuged at 13,000 × *g* for 15 min at 4 °C, and 30 *μ*g of the cell lysate was separated by to 7.5% SDS-polyacrylamide gel electrophoresis. The separated proteins were transferred onto a PVDF membrane (Bio-Rad, CA, USA). Nonspecific binding to the membrane was blocked by incubation with blocking buffer (Thermo Fisher Scientific) for 60 min at room temperature. Then, the membrane was incubated with anti-mouse iNOS (1 : 500; Santa Cruz, CA, USA) and anti-mouse COX-2 (1 : 1000; BD Biosciences Pharmingen, CA, USA) overnight at 4°C. After washing, the blots were incubated with horseradish peroxidase-conjugated goat anti-mouse IgG secondary antibody (1 : 1000; Santa Cruz) for 60 min at room temperature. The bands were visualized by using the LAS-4000 luminescent image analyzer (GE Healthcare Life Sciences, NJ, USA) and ECL detection reagent (GE Healthcare Life Sciences).

2.11. Collagenase Assay {#sec2.11}
-----------------------

The collagenase assay was performed as described previously \[[@B15]\]. Collagenase (5 *μ*g) and 4-phenylazobenzyloxycarbonyl-L-Pro-L-Leu-Gly-L-Pro-D-Arg (0.5 mg), as a substrate of collagenase, were added to 0.1 M Tris buffer (pH 7.4) in the presence or absence of samples to a total volume of 1.7 mL. The mixture was incubated at 37°C for 30 min, and 1 mL of 25 mM citric acid solution was added to terminate the enzyme reaction. Ethyl acetate (5 mL) was added, and the absorbance of the organic layer was measured by using UV spectrophotometry at 320 nm to calculate the inhibitory activity. The collagenase inhibitory activity was calculated from equation ([3](#EEq3){ref-type="disp-formula"}), where OD control = OD of the control with collagenase-OD of the control without collagenase, and OD sample = OD of the test sample with collagenase-OD of the test sample without collagenase:$$\begin{matrix}
{\text{inhibition rate }\left( \text{\%} \right) = \frac{\left( {\text{OD control} - \text{OD sample}} \right)}{\text{OD control}}\, \times 100.} \\
\end{matrix}$$

2.12. Statistical Analysis {#sec2.12}
--------------------------

All data were expressed as mean ± SD values and were evaluated by using one-way analysis of variance (ANOVA), followed by the Student--Newman--Keuls (S--N--K) test; statistical analyses were computed using Statistical Package for the Social Sciences (SPSS, Chicago, IL, USA) software package. Values were considered significantly different if the *p* value was less than 0.05. Different superscripts in the same column indicate that values are significantly distinct from the other data.

3. Results and Discussion {#sec3}
=========================

3.1. Isolation and Structural Identification of the Compounds {#sec3.1}
-------------------------------------------------------------

We isolated 10 compounds from FAS, namely, lignans (**1**, **2**, **6**, **7**), phenolic acids (**4**, **5**, **9**), and others (**3**, **8**, **10**). The isolated compounds were identified as acanthoside D (**1**) \[[@B16]\], acanthoside B (**2**) \[[@B17]\], daucosterol (**3**) \[[@B18]\], protocatechuic acid (**4**) \[[@B19]\], chlorogenic acid methyl ester (**5**) \[[@B20]\], ciwujiatone (**6**) \[[@B21]\], syringaresinol (**7**) \[[@B22]\], farnesol (**8**) \[[@B23], [@B24]\], 3,4-dicaffeoylquinic acid (**9**) \[[@B25]\], and falcarindiol (**10**) \[[@B26]\] through comparison of their spectral data with the values reported in other studies ([Figure 1](#fig1){ref-type="fig"}). Structures of the 10 compounds isolated from FAS were identified by analysis of ^1^H and ^13^C NMR spectra compared with references. ^1^H and ^13^C NMR spectra of the compounds (1--10) were included in Supplementary Materials as [Figure S1](#supplementary-material-1){ref-type="supplementary-material"}--[S10](#supplementary-material-1){ref-type="supplementary-material"}.

Acanthoside D (**1**): brown powder, ^1^H-NMR (600 MHz, DMSO-d6 + D~2~O): *δ* 6.61 (4H, s, H-2′, 6′, 2″, 6″), 4.84 (2H, d, *J* = 4.2 Hz, H-1‴, 1″″), 4.63 (2H, d, *J* = 3.6 Hz, H-2, 6), 4.16 (2H, dd, *J* = 9.0, 6.6 Hz. H-4*β*, 8 *β*), 3.78 (2H, dd, *J* = 9.0, 3.6 Hz, H-4*α*, 8*α*), 3.71 (12H, s, H-3′, 5′ 3″ 5″-OCH3), 3.54 (2H, m, H-6‴*β*, 6″″*β*), 3.36 (2H, dd, *J* = 6, 12.0 Hz, H-6‴*α*, 6″″*β*), 3.17-3.04 (8H, m, 2‴, 3‴, 4‴, 5‴, 2″″, 3″″, 4″″, 5″″), 3.10-3.07 (2H, m, H-1, 5); ^13^C-NMR (150 MHz, DMSO-d6 + D~2~O): *δ* 153.1(C-3′, 5′, 3″, 5″), 137.7 (C-4′, 4″), 134.2 (C-1′, 1″), 104.7 (C-2′, 6′, 2″, 6″), 103.2 (C-1‴, 1″″), 85.6 (C-2, 6), 77.6 (C-5‴, 5″″), 76.9 (C-3‴, 3″″), 74.6 (C-2‴, 2″″), 71.9 (C-4, 8), 70.3 (C-4‴, 4″″), 61.3 (C-6‴, 6″″), 56.9 (C-3′, 5′, 3″, 5″--OCH3), 54.1 (C-1, 5).

Acanthoside B (**2**): brown powder, ^1^H-NMR (600 MHz, DMSO-d6 + D~2~O): *δ* 6.61 (2H, s, H-2″, 6″), 6.55 (2H, s, H-2′, 6′), 4.83 (1H, m, H-1‴), 4.63 (1H, d, *J* = 4.8 Hz, H-2), 4.57 (1H, d, *J* = 4.2, H-6), 4.13 (2H, m, H-4*β*, 8 *β*), 3.75 (2H, dd, *J* = 5.4, 3.6 Hz, H-4*α*, 8*α*), 3.71 (6H, s, OCH3-3″,5″), 3.70 (6H, s, OCH3-3′,5′), 3.54 (1H, dd, *J* = 12.0, 1.8 Hz, H-6‴*α*), 3.60 (1H, m, H-6‴*β*), 3.16 (2H, m, H-2‴, 3‴), 3.10 (1H, m, 4‴), 3.01 (2H, m, H-1, 5), 2.99 (1H, H-5‴); ^13^C-NMR (150 MHz, DMSO-d6 + D~2~O): *δ* 153.1 (C-3′, 5′), 148.3 (C-3″, 5″), 137.8 (C-1′), 135.2 (C-4″), 134.1 (C-4′), 131.9 (C-1″), 104.6 (C-2′, 6′), 104.1 (C-2″, 6″), 103.2 (C-1‴), 85.9 (C-6), 85.6 (C-2), 77.6 (C-5‴), 76.8 (C-3‴), 74.5 (C-2‴), 71.8 (C-8), 71.7 (C-4), 70.3 (C-4‴), 60.6 (C-6‴), 56.9 (C-3′, 5′-OCH3), 56.5 (C-3″, 5″-OCH3), 54.2 (C-1), 54.1 (C-5).

Daucosterol (**3**): white powder, ^13^C-NMR (150 MHz, pyridine-d5): *δ* 140.7 (C-5), 121.8 (C-6), 102.4 (C-1′), 78.5 (C-3), 78.4 (C-3′), 77.9 (C-5′), 75.2 (C-2′), 71.5 (C-4′), 62.7 (C-6′), 56.7 (C-14), 56.1 (C-17), 50.2 (C-9), 45.9 (C-24), 42.3 (C-13), 39.8 (C-4), 39.2 (C-12), 37.3 (C-1), 36.8 (C-10), 36.2 (C-20), 34.0 (C-22), 32.0 (C-7), 31.9 (C-8), 30.1 (C-2), 29.3 (C-25), 28.4 (C-16), 26.2 (C-23), 24.4 (C-15), 23.2 (C-28), 21.1 (C-11), 19.8 (C-27), 19.3 (C-19), 19.0 (C-26), 18.9 (C-21), 12.0 (C-29), 11.8 (C-18).

Protocatechuic acid (**4**): brown needle, ^1^H-NMR (600MHz, DMSO-d6 + D~2~O): *δ* 7.29 (1H, d, *J* = 1.8 Hz, H-2), 7.25 (1H, dd, *J* = 8.4, 1.8 Hz, H-6), 6.75 (1H, d, *J* = 8.4 Hz, H-5); ^13^C-NMR (150MHz, DMSO-d6 + D~2~O): *δ* 167.9 (C-7), 150.3 (C-4), 145.2 (C-3), 122.5 (C-1), 122.1 (C-6), 117.0 (C-2), 115.6 (C-5).

Chlorogenic acid methyl ester (**5**): brown powder, ^1^H-NMR (600 MHz, DMSO-d6 + D~2~O): *δ* 7.32 (1H, d, *J* = 16.2 Hz, H-7′), 6.99 (1H, d, *J* = 2.4 Hz, H-2′), 6.92 (1H, dd, *J* = 8.4, 2.4 Hz, H-6′), 6.73 (1H, d, *J* = 8.4 Hz, H-5′), 6.07 (1H, d, *J* = 16.2 Hz, H-8′), 4.96 (1H, dd, *J* = 9.6, 5.4 Hz, H-3), 3.83 (1H, dt, *J* = 9.0, 3.6, H-5), 3.50 (3H, s, H--CH3), 2.05 (2H, m, H-2*α*, 2*β*), 1.80 (1H, m, H-6*α*), 1.71 (1H, m, H-6*β*); ^13^C-NMR (150 MHz, DMSO-d6 + D~2~O): *δ* 174.1 (C-7), 166.0 (C-9′), 148.8 (C-4′), 145.9 (C-3′), 145.7 (C-7′), 126.0 (C-1′), 122.0 (C-6′), 116.3 (C-2′), 114.9 (C-5′), 114.4 (C-8′), 73.5 (C-1), 71.5 (C-5), 69.7 (C-4), 52.4 (C--CH3), 37.6 (C-6), 35.5 (C-2).

Ciwujiatone (**6**): yellowish powder, ^1^H-NMR (600 MHz, DMSO-d6 + D~2~O): *δ* 7.25 (2H, s, H-2, 6), 6.56 (2H, s, H-2′, 6′), 4.49 (1H, d, *J* = 7.8 Hz, H-7′), 4.13 (1H, m, H-8), 4.02(2H, m, H-9), 3.78 (6H, s, H-3, 5-OCH3), 3.40 (6H, s, H-3′, 5′-OCH3), 3.46 (2H, m, H-9′), 2.43 (1H, m, H-8); ^13^C-NMR (150 MHz, DMSO-d6 + D~2~O): *δ* 198.8 (C-7), 148.2 (C-3′, 5′), 148.2 (C-3, 5), 141.9 (C-4), 135.1 (C-4′), 132.4 (C-1′), 127.4 (C-1), 106.9 (C-2, 6), 104.4 (C-2′, 6′), 83.6 (C-7′), 70.3 (C-9), 60.3 (C-9′), 56.6 (C-3), 56.6 (C-5), 56.5 (C-3′, 5′), 56.0 (C-8′), 49.0 (C-8).

Syringaresinol (**7**): light brown powder, ^1^H-NMR (600 MHz, CDCl~3~): *δ* 6.57 (4H, s, H-2″, 6″, 2‴, 6‴), 4.71 (2H, m, H-2, 6), 4.27 (2H, m, H-4*α*, 8*α*), 3.89 (2H, m, H-4*β*, 8*β*), 3.88 (12H, s, H-3″, 5″, 3‴, 5‴-OCH3), 3.08 (2H, m, H-1, 5); ^13^C-NMR (150 MHz, CDCl~3~): *δ* 147.2 (C-3′, 5′), 134.3 (C-4′), 132.2 (C-1′), 102.7 (C-2′, 6′), 86.2 (C-2, 6), 71.9 (C-4, 8), 56.5 (C-3″, 5″, 3‴, 5‴-OCH3), 54.4 (C-1, 5).

Farnesol (**8**): yellowish oil, ^1^H-NMR (600 MHz, CDCl~3~): *δ* 5.39 (1H, t, *J* = 7.2 Hz, H-2), 5.13 (2H, m, H-6, 10), 4.13 (2H, d, *J* = 7.2 Hz, H-1), 2.10-1.95 (4H, m, H-4, 5, 8, 9), 1.65 (6H, brs, H-12, 15), 1.58 (6H, brs, H-13, 14); ^13^C-NMR (150 MHz, CDCl~3~): *δ* 139.9 (C-3), 135.4 (C-7), 131.4 (C-11), 124.4 (C-10), 123.9 (C-6), 123.3 (C-2), 59.4 (C-1), 39.8 (C-8), 39.6 (C-4), 26.8 (C-9), 26.4 (C-5), 25.8 (C-12), 17.8 (C-15), 16.4 (C-13), 16.1 (C-14).

3,4-dicaffeoylquinic acid (**9**): brown powder, ^1^H-NMR (600 MHz, CD~3~OD + D~2~O): *δ* 7.57 (1H, d, *J* = 15.6 Hz, H-7′), 7.49 (1H, d, *J* = 16.2 Hz, H-7″), 7.00 (2H, m, H-2′, 2″), 6.88 (2H, dd, *J* = 8.4, 1.2 Hz, H-6′, 6″), 6.73 (1H, d, *J* = 8.4Hz, H-5′, 5″), 6.27(1H, d, *J* = 15.6 Hz, H-8′), 6.17(1H, d, *J* = 15.6 Hz, H-8″), 5.61 (1H, m, H-3), 5.09 (1H, m, H-4), 3.36 (1H, m, H-5), 2.50-2.02 (4H, m, H-2, 6); ^13^C-NMR (150 MHz, CD~3~OD + D~2~O): *δ*174.0 (C-7), 167.4 (C-9′), 167.1 (C-9″), 148.3 (C-4′, 4″), 146.5(C-7′), 146.4 (C-7″), 145.3 (C-3′), 145.3 (C-3″), 126.4 (C-1′), 126.3 (C-1″), 122.0 (C-6′), 122.0 (C-6″), 115.2 (C-5′, 5″), 113.9 (C-2′, 2″), 113.4 (C-8′), 113.4 (C-8″), 74.6 (C-1), 74.5 (C-4), 68.6 (C-5), 67.8 (C-3), 37.2 (C-2), 37.0 (C-6).

Falcarindiol (**10**): brown oil, ^1^H-NMR (600 MHz, CDCl~3~): *δ* 5.92 (1H, ddd, *J* = 16.8, 10.2, 5.4Hz, H-2), 5.60 (1H, ddt, *J* = 10.8, 7.8, 1.2 Hz, H-10), 5.50 (2H, m, H-1*α*, 9), 5.25 (1H, m, H-1*β*), 5.20 (1H, d, *J* = 7.8 Hz, H-8), 4.93 (1H, brd, *J* = 5.4Hz, H-3), 2.10 (2H, m, H-11), 1.37 (2H, m, H-12), 1.25 (8H, m, H-13, 14, 15, 16) 0.87 (3H, t-like, *J* = 7.5 Hz, H-17); ^13^C-NMR (150 MHz, CDCl~3~): *δ* 135.9 (C-2), 134.8 (C-10), 127.7 (C-9), 117.4 (C-1), 79.9 (C-7), 78.3 (C-4), 70.4 (C-5), 68.8 (C-6), 63.6 (C-3), 58.7 (C-8), 31.9 (C-15), 31.0 (C-13), 29.4 (C-14), 29.2 (C-12), 27.8 (C-11), 22.7 (C-16), 14.2 (C-17).

3.2. HPLC Analysis Results {#sec3.2}
--------------------------

The compounds in the FAS were compared with AS by using HPLC. In this study, the remarkable differences were found in the contents of several compounds that acanthoside D (**1**) was lower and syringaresinol (**7**) and protocatechuic acid (**4**) were higher in FAS than in AS ([Figure 2](#fig2){ref-type="fig"}, [Table 2](#tab2){ref-type="table"}).

3.3. Cell Viability {#sec3.3}
-------------------

Prior to the biological assays, the MTT assays were performed using the extracts and each compound from the FAS extract. The extracts and compounds did not affect the cell viability (\>80%) at the experimental doses ([Figure 3](#fig3){ref-type="fig"}). These results demonstrated that the concentration used in the inhibition experiments of the production of NO and cytokines and inflammatory molecules by the extracts and compounds was not cytotoxic.

To assess the anti-inflammatory activity of AS, FAS, and compounds **1**--**10** isolated from FAS, the inhibitory effects on NO production in RAW 264.7 cells were evaluated. FAS (IC~50~ = 12.31 ± 0.92 *μ*g/mL) had strong inhibitory effects on NO production compared with AS (IC~50~ = 26.56 ± 1.28 *μ*g/mL) and effects similar to those of the positive control, L-NMMA (IC~50~ = 10.16 ± 0.85 *μ*g/mL). Most of the isolated compounds had strong inhibitory effects on NO production ([Table 3](#tab3){ref-type="table"}). Some compounds isolated from FAS, **7** (IC~50~ = 26.56 ± 1.28 *μ*M), **8** (IC~50~ = 40.63 ± 3.38 *μ*M), **9** (IC~50~ = 7.95 ± 2.03 *μ*M), and **10** (IC~50~ = 21.87 ± 1.02 *μ*M), more strongly inhibited NO production than the positive control, L-NMMA (IC~50~ = 19.68 ± 5.38 *μ*M). In particular, the aglycone form (**7**) showed better activity than the glycoside (**1**).

3.4. Inhibition of iNOS and COX-2 Levels {#sec3.4}
----------------------------------------

To further characterize the mechanisms underlying the inhibition of the LPS-induced production of NO by the extracts and compounds, western blotting assays were performed. Four compounds (**7**--**10**) that showed strong inhibitory activity in the NO production assay were selected for the test of iNOS and COX-2; in addition, compound **1** was selected for comparison with its aglycone, **7**. The levels of iNOS and COX-2 were significantly increased in the LPS-stimulated cells compared with the control cells ([Figure 4](#fig4){ref-type="fig"}). Treatment with AS, FAS, and the selected compounds significantly inhibited iNOS expression in a concentration-dependent manner; similar results were obtained for COX-2. The FAS extract strongly inhibited iNOS and COX-2 levels compared with AS. Most of the compounds decreased iNOS and COX-2 production, especially **9** and **10**, and the aglycone (**7**) showed better activity than the glycoside (**1**). These results indicated that the extracts and compounds inhibited NO production through a decrease in iNOS and COX-2 expression in the LPS-stimulated RAW 264.7 cells.

3.5. Effects on Cytokine Production {#sec3.5}
-----------------------------------

The inhibition of cytokine (IL-6 and TNF-*α*) production was analyzed by using ELISA. RAW 264.7 macrophage cells were exposed to LPS, and the cytokine levels in these cells were measured for their evaluation of the inhibitory effects of AS, FAS, and the isolated compounds. In the LPS-treated group (control), IL-6 and TNF-*α* levels were detected to be 548.12 pg/mL and 777.89 pg/mL, respectively. In the AS and FAS treated groups, IL-6 and TNF-*α* levels were decreased (Figures [5(a)](#fig5){ref-type="fig"} and [5(b)](#fig5){ref-type="fig"}). The FAS inhibited cytokines to a greater extent than AS did. RAW 264.7 cells were exposed to LPS, and the inhibitory effects of compounds (**1** and **7--10**) on cytokine production (IL-6 and TNF-*α*) were measured. In the LPS-treated group (control), IL-6 and TNF-*α* levels were 262.07 pg/mL and 302.88 pg/mL, respectively. IL-6 and TNF-*α* levels were decreased by treatment with the selected compounds. And the **9**, **10,** and the aglycone **7** showed better activity than the glycoside (Figures [5(c)](#fig5){ref-type="fig"} and [5(d)](#fig5){ref-type="fig"}).

3.6. Effects on Collagenase Reaction {#sec3.6}
------------------------------------

The inhibition of collagenase by AS, FAS, and the isolated compounds was evaluated. FAS (79%) more strongly inhibited collagenase when compared with AS (33%; [Table 4](#tab4){ref-type="table"}). The effects of five compounds (**1** and **7--10**) on the collagenase reaction were measured. Compounds **9** (90.38%) and **10** (52.88%) showed potent inhibitory activities, and **1**, **7**, and **8** exhibited moderate activities. The aglycone form (**7**) (23.08%) showed better activity than the glycoside form (**1**) (15.38%).

4. Discussion {#sec4}
=============

There are many reports that the linkage of glycosyl groups of the aglycone can alter their bioactivities \[[@B27], [@B28]\]. The variation of natural products and their bioactivities by fermentation is also reported. For example, some researchers reported that rare ginsenosides could be produced from major ginsenosides by microorganisms \[[@B27], [@B29]\]. The aglycones of ginsenosides are more easily absorbed from the small intestine than glycosides and have altered physiological actions *in vitro* and *in vivo* \[[@B30], [@B31]\]. This has been reported for not only ginsenosides, but also other compounds, including tannins and fatty acids. *L. plantarum* subsp. *argentoratensis* has tannase and can decompose tannin; thus, it has been used for the initial degradation of complex tannins \[[@B32]\]. The fermentation of *Vigna sinensis* L., cowpea, increased phenolic compound content and enhanced antioxidant activity \[[@B33]\]. In another study, microorganisms converted linoleic and linolenic acids to unsaturated hydroxy fatty acids \[[@B34]\]. Syringaresinol, the aglycone form of lignan (**7**), has been reported to more strongly inhibit proinflammatory molecules (prostaglandin E~2~, TNF-*α*, iNOS, and COX-2) compared with acanthoside D, the glycoside form of lignan (**1**) \[[@B3]\]. In addition, caffeic acid, quinic acid, and protocatechuic acid, which are common in plants, have antioxidant, antitumor, and anti-inflammatory activities \[[@B35]\]. In the present study, FAS showed stronger anti-inflammatory activities than AS. Moreover, the activity of syringaresinol (**7**) was better than that of acanthoside D (**1**). The HPLC analysis showed that the content of syringaresinol, the aglycone (**7**), increased during fermentation and the content of acanthoside D, the glycoside (**1**), decreased during fermentation. Protocatechuic acid (**4**) content also increased by bioconversion, and these compounds had good inhibitory effects on inflammatory-related factors. These results indicated that the variations due to bioconversion led to significant differences in the anti-inflammatory effects of the FAS and AS.

5. Conclusion {#sec5}
=============

The biotransformation of the *A. sessiliflorus* extract via fermentation was performed. The inhibitions of the production of NO and inflammatory molecules by AS, FAS, and the isolated compounds were measured in vitro. The results showed that the content of the compounds was different in FAS and AS. The increased compounds, syringaresinol (**7**) and protocatechuic acid (**4**), showed better activity than acanthoside D (**1**). Moreover, the anti-inflammatory activities of FAS were stronger than those of AS. These results indicated that FAS and the isolated compounds may be a potential treatment for inflammatory disorders such as arthritis.
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###### 

Supplementary materials file includes NMR spectra of the 10 compound isolated from FAS. Figure S1-1: ^1^H-NMR spectrum of compound **1** (600 MHz, DMSO + D~2~O); Figure S1-2: ^13^C-NMR spectrum of compound **1** (150 MHz, DMSO + D~2~O); Figure S2-1: ^1^H-NMR spectrum of compound **2** (600 MHz, DMSO + D~2~O); Figure S2-2: ^13^C-NMR spectrum of compound **2** (150 MHz, DMSO + D~2~O); Figure S3-1: ^1^H-NMR spectrum of compound **3** (600 MHz, pyridine-d5); Figure S3-2: ^13^C-NMR spectrum of compound **3** (150 MHz, pyridine-d5); Figure S4-1: ^1^H-NMR spectrum of compound **4** (600 MHz, DMSO + D~2~O); Figure S4-2: ^13^C-NMR spectrum of compound **4** (150 MHz, DMSO + D~2~O); Figure S5-1: ^1^H-NMR spectrum of compound **5** (600 MHz, DMSO + D~2~O); Figure S5-2: ^13^C-NMR spectrum of compound **5** (150 MHz, DMSO + D~2~O); Figure S6-1: ^1^H-NMR spectrum of compound **6** (600 MHz, DMSO + D~2~O); Figure S6-2: ^13^C-NMR spectrum of compound **6** (150 MHz, DMSO + D~2~O); Figure S7-1: ^1^H-NMR spectrum of compound **7** (600 MHz, CDCl~3~); Figure S7-2: ^13^C-NMR spectrum of compound **7** (150 MHz, CDCl~3~); Figure S8-1: ^1^H-NMR spectrum of compound **8** (600 MHz, CDCl~3~); Figure S8-2: ^13^C-NMR spectrum of compound **8** (150 MHz, CDCl~3~); Figure S9-1: ^1^H-NMR spectrum of compound **9** (600 MHz, CD~3~OD + D~2~O); Figure S9-2: ^13^C-NMR spectrum of compound **9** (150 MHz, CD~3~OD + D~2~O); Figure S10-1: ^1^H-NMR spectrum of compound **10** (600 MHz, CDCl~3~); Figure S10-2: ^13^C-NMR spectrum of compound **10** (150 MHz, CDCl~3~).

###### 

Click here for additional data file.

![Structures of compounds **1**--**10.**](ECAM2020-6749425.001){#fig1}

![HPLC peaks for comparison of FAS and AS.](ECAM2020-6749425.002){#fig2}

![Cell viability assay. (a) Effects of AS (○) and FAS (●) extracts on the viability of RAW 264.7 cells. (b) Effects of compounds **1**--**10** on the viability of RAW 264.7 cells. **1** (●), **2** (○), **3** (▼), **4** (△), **5** (■), **6** (□), **7** (◆), **8** (◇), **9** (▲), and **10** (▽).](ECAM2020-6749425.003){#fig3}

![Expression of iNOS and COX-2 (western blotting). (a) Effects of AS and FAS on the expression of iNOS and COX-2 in the LPS-stimulated RAW 264.7 cells. 12.5, 12.5 *μ*g/mL; 25, 25 *μ*g/mL. (b) Effects of the selected compounds on the expression of iNOS and COX-2 in the LPS-stimulated RAW 264.7 cells. 1, 50 *μ*M; 2, 25 *μ*M.](ECAM2020-6749425.004){#fig4}

![Effects of AS and FAS on IL-6 and TNF-*α* production in RAW 264.7 cells. (a) Effects of the *A. sessiliflorus* and FAS extracts on IL-6 production. (b) Effects of AS and FAS on TNF-*α* production. (c) Effects of the isolated compounds on IL-6 production. (d) Effects of the selected compounds on TNF-*α* production. The results are expressed as the mean ± SD of triplicate experiments. ^\#\#\#^*p* \< 0.001 when compared with the blank; ^*∗∗∗*^ *p* \< 0.001, ^*∗∗*^*p* \< 0.01, and ^*∗*^*p* \< 0.05 when compared with the control.](ECAM2020-6749425.005){#fig5}

###### 

HPLC analysis conditions.

  HPLC conditions                                                                                              
  ------------------------------------- ------------------------------------------------- -------------------- -------
  Mobile phase                          \(A\) 0.2% acetic acid in H~2~O                   Flow rate 1 mL/min   
  \(B\) ACN                             Injection vol. 10 *μ*L                                                 
                                                                                                               
  Gradient profile                      Time (min)                                        A (%)                B (%)
  0                                     95                                                5                    
  40                                    40                                                60                   
  50                                    0                                                 100                  
  55                                    0                                                 100                  
                                                                                                               
  High-pressure liquid chromatography                                                                          
  Controller                            Waters 2695 separation module                                          
  Column                                Hector C~18~ HPLC column (5 *μ*m, 250 × 4.6 mm)                        
  Detector                              Waters 996 photodiode array detector                                   

###### 

Retention time and percentage of compounds **1**, **4**, and **7** in AS and FAS.

  Compound   Retention time (min)   AS (%)   FAS (%)
  ---------- ---------------------- -------- ---------
  **1**      14.9                   13.67    2.19
  **4**      10.4                   1.68     3.50
  **7**      26.1                   4.45     9.94

###### 

IC~50~ values for inhibition of NO production by AS, FAS, and isolated compounds **1**--**10**.

  Extract                IC~50~ (*μ*g/mL)   Compound               IC~50~ (*μ*M)
  ---------------------- ------------------ ---------------------- --------------------
  AS                     26.56 ± 1.28^b^    **1**                  57.71 ± 2.33^c^
  FAS                    12.37 ± 0.92^a^    **2**                  \>100^e^
  [l]{.smallcaps}-NMMA   10.16 ± 0.85^a^    **3**                  \>100^d^
                                            **4**                  40.63 ± 3. 38^b,c^
                                            **5**                  45.80 ± 8.28^b,c^
                                            **6**                  \>100^d^
                                            **7**                  26.16 ± 1. 37^a,b^
                                            **8**                  37.35 ± 7.97^b,c^
                                            **9**                  7.95 ± 2.03^a^
                                            **10**                 21.87 ± 1.02^a,b^
                                            [l]{.smallcaps}-NMMA   19.68 ± 5.38^a,b^

Values are expressed as the mean ± SD of triplicate experiments. Values with different superscripts (a--e) in the same columns are significantly different (*p* \< 0.05).

###### 

Effects of AS, FAS, and the selected compounds on the collagenase reaction.

  Extract (25 *μ*g/mL)   Inhibition (% of control)   Extract (50 *μ*M)   Inhibition (% of control)
  ---------------------- --------------------------- ------------------- ---------------------------
  AS                     33.00                       **1**               15.38
  FAS                    79.00                       **7**               23.08
                                                     **8**               22.12
                                                     **9**               90.38
                                                     **10**              52.88

[^1]: Guest Editor: Xiangguo Shi
